Medical technology start-up SurgMark aims to enter the US market
Press Release Medical technology start-up SurgMark aims to enter the US market FDA Approval Sought for Biocompatible SchurSign® Tissue...
Medical technology start-up SurgMark aims to enter the US market
Production of the marker started
Dr Christine König elected to the BGB Board of Life Science Nord e.V.
Dr Christine König appointed to the Advisory Board of the Female Founders of LSX
SurgMark heads for market with novel SchurSign technology
Europe Healthtech - Unicorn Battle®
HH health Startups meet US investors